🎤 Join our founder group to hear from firms like NEA on What it takes to raise a Series A?

Register
Peter Kolchinsky

Peter Kolchinsky

Managing Partner·RA Capital Management

Boston, Massachusetts, United States

Bio

Professional summary

Peter Kolchinsky is a founder and Managing Partner at RA Capital Management. RA Capital's official profile says he invests in public and private companies developing drugs, medical devices, diagnostics, and research tools, and serves on boards of life science companies. He also leads engagement and publishing efforts focused on healthcare collaboration, authored The Great American Drug Deal and The Entrepreneur's Guide to a Biotech Startup, and founded No Patient Left Behind. He holds a BA from Cornell University and a PhD in Virology from Harvard University.

Investment focus

Stage, sector, and overall fit

Stage

Public healthcare companiesPrivate healthcare companiesCompany formation and multi-stage life sciences

Sector

BiotechnologyDrugsMedical devicesDiagnosticsResearch tools

Thesis

DrugsMedical devicesDiagnosticsResearch toolsLife science companies

Notable companies

Selected portfolio companies the partner has backed

{ "name": "No Patient Left Behind", "relationship": "Founder and Director", "confidence": "high", "source_basis": "official profile" }{ "name": "RA Capital Management", "relationship": "Founder and Managing Partner", "confidence": "high", "source_basis": "official profile" }

How to approach

Framing and angles for outreach

Pitch framing

Lead with evidence-based life-sciences value creation, clinical differentiation, and a thoughtful view on healthcare access or stakeholder alignment.

Personalization hooks

  1. 1Author of The Great American Drug Deal
  2. 2Author of The Entrepreneur's Guide to a Biotech Startup
  3. 3Founder of No Patient Left Behind
  4. 4Cornell BA and Harvard PhD in Virology

Recent signals

What the partner has said or done recently

  • Official profile emphasizes ongoing engagement and publishing efforts around healthcare stakeholders and biotechnology innovation.

Background

Career, education, and skills

Career history

  • RA Capital ManagementCo-Founder & Managing Partner2001

Education

  • Harvard UniversityPh.D., Biology/Life Sciences

Skills

Biotech investingDrug pricing policyHealthcare advocacyBoard governanceBiotech M&AWriting/publishing

Other partners at RA Capital Management

12 more profiles

Abigail (Lauterbach) Schmitz

Abigail (Lauterbach) Schmitz

Senior Associate

RA Capital Management

TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.

biotech diligencecompetitive landscapesportfolio strategyTechAtlastherapeutics
Adam Prince, MD

Adam Prince, MD

Senior Associate, Strategic Initiatives

RA Capital Management

RA Capital TechAtlas senior associate with cardiology and medical training.

biotech diligencecardiologyhealth innovationportfolio strategyTechAtlas
Alana MacDonald, Ph.D.

Alana MacDonald, Ph.D.

Senior Associate

RA Capital Management

Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.

biotechnologycompetitive landscapesportfolio strategyTechAtlastherapeutics
Alejandro Sevilla

Alejandro Sevilla

Associate

RA Capital Management

Planetary Health associate focused on climate-tech landscapes and investment evaluation.

advanced batteriesclimate technologycompetitive landscapesenergy storageplanetary health
Alex Miller

Alex Miller

Senior Associate, Venture

RA Capital Management

Venture senior associate focused on biotech diligence and portfolio strategy.

biotechnologyprogram strategyTechAtlastherapeuticsventure investing
Alex T. Zhang

Alex T. Zhang

Vice President, Structured Capital

RA Capital Management

Structured Capital VP focused on healthcare and life-sciences credit investments.

commercial-stage healthcarehealthcare creditlife sciencesprivate creditstructured capital
Alexander Martinez-Forte

Alexander Martinez-Forte

Director, Quantitative Research & Strategy

RA Capital Management

RA Capital director leading quantitative analyses for investment decisions and portfolio management.

Data scienceFinancial riskHealthcare investingInvestment analyticsPortfolio managementQuantitative research
Allison Harrigan

Allison Harrigan

Senior Director Corporate Development

RA Capital Management

Raven corporate development leader focused on biotech company creation.

Biotech strategyBusiness developmentCompany creationCorporate developmentDrug discovery
Alyssa Larson

Alyssa Larson

Director, Healthcare Specialist - Investor Relations

RA Capital Management

TechAtlas director supporting healthcare diligence and investor relations.

BiochemistryCompetitive landscapesHealthcare diligenceInvestor relationsTechAtlas
Ami Thakrar, PhD

Ami Thakrar, PhD

Associate

RA Capital Management

TechAtlas associate focused on biotech diligence and program strategy.

biotechnologycompetitive landscapesmedical engineeringprogram strategyTechAtlas
Anish K. More

Anish K. More

Vice President, Corporate Development

RA Capital Management

Raven corporate-development VP focused on investment evaluation and NewCo creation.

company creationcorporate developmenthealthcare servicesNewCosRaven
Anurag Kondapalli

Anurag Kondapalli

Principal

RA Capital Management

Principal investing across public and private healthcare technology and services companies.

healthcare serviceshealthcare technologyprivate investmentspublic investmentsstructured growth capital